Clinical Trial Update: Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating quetiapine extended-release (XR) for bipolar disorder patients with comorbid generalized anxiety disorder; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Generalized Anxiety Disorder

Drugs mentioned

• Quetiapine XR (quetiapine)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Bipolar Disorder, Anxiety | Phase 3 | Status: COMPLETED | Results posted: 2013-10-11